FMA
EW icon

FNY Managed Accounts’s Edwards Lifesciences EW Stock Holding History

FNY Managed Accounts’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$9K Buy
+198
New +$8.6K 0.01% 152

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

FNY Managed Accounts's EW Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Edwards Lifesciences (EW) in Q1 2018: 198 shares worth $9K. The stake represents 0.01% of the portfolio and ranks #152 among its holdings.

815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

  • FNY Managed Accounts held 198 shares of Edwards Lifesciences worth $9K as of Q1 2018.
  • Edwards Lifesciences was a new FNY Managed Accounts position in Q1 2018.
  • Edwards Lifesciences made up 0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #152 holding.
  • 815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.